诺南综合征患者的复发性细胞炎和细菌病:一个病例报告
Takayuki Koike1, Michihito Fukushiro1, Ayaka Ueno1
1Department of Dermatology, Shimane University Faculty of Medicine, Izumo, Japan.
概括
诺南综合征 (NS) 患有蛋白质丧失肠道病变 (PLE) 和淋巴的患者面临复发性细胞质炎. MEK 抑制剂在治疗NS中严重的淋巴系统疾病和相关感染方面表现有前途.
科学领域:
- 遗传学 是一个遗传学.
- 免疫学 免疫学 免疫学
- 血管外科 血管外科
背景情况:
- 努南综合征 (NS) 是一种与20%的患者淋巴异常相关的RAS病变.
- 损失蛋白质的肠道病变 (PLE) 与肠道淋巴结膜病变可以加剧NS患者的细胞炎等感染.
- 复发性纤维炎是NS患者患有淋巴和PLE的重要并发症.
研究的目的:
- 突出在患有努南综合征,蛋白质损失肠病和淋巴的患者中治疗复发性纤维炎的挑战.
- 讨论MEK抑制剂作为RASopathies中淋巴系统疾病的向治疗的潜力.
主要方法:
- 一名28岁的日本男子患有诺南综合征,患有复发性纤维炎的案例介绍.
- 检查患者病史,包括失去蛋白质的肠道病变,肠道淋巴管切开症,以及之前的淋巴管静脉解剖 (LVA) 程序.
- 讨论NS中淋巴系统疾病和相关感染的当前和新兴治疗策略.
主要成果:
- 患者出现了广泛的细胞炎和败血症,需要长时间的抗生素治疗.
- 尽管之前进行了干预和抗生素预防,但该患者经历了多次细胞炎发作.
- 淋巴细胞静脉解 (LVA) 已在治疗NS患者的四肢淋巴方面表现出有效性.
结论:
- 复发性纤维炎在诺南综合征患者中具有重大挑战,同时存在PLE和淋巴.
- 使用MEK抑制剂的向分子疗法代表了治疗严重淋巴系统疾病和RASopathies中相关并发症的有希望的途径.
- 对NS中淋巴细胞疾病的MEK抑制剂的进一步研究是有必要的.
相关概念视频
01:27Acute Pyelonephritis I: Introduction
Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such as Proteus,...
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
01:24Bacterial Meningitis
Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
01:22Bacterial Meningitis I: Introduction
Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
01:26Bacterial Meningitis II: Pathophysiology
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...